About Korean vaccine
Korean vaccine is a company based in Ansan-si (South Korea) founded in 1956. It operates as a B2B and Contract Manufacturing. Korean vaccine offers products and services including Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and Catheter. Korean vaccine operates in a competitive market with competitors including Hospira, 410 Medical, Ivenix, Belmont Medical Technologies and IRadimed, among others.
- Headquarter Ansan-si, South Korea
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name (주)한국백신
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Korean vaccine
Korean vaccine offers a comprehensive portfolio of products and services, including Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and Catheter.
Influenza vaccine for seasonal flu prevention and protection.
Divided influenza vaccine for immunization purposes.
Device for vaccine administration and medical injections.
Component for safe delivery of vaccines and fluids.
Tool for medical procedures and fluid management.
System for intravenous delivery of medications.
Funding Insights of Korean vaccine
Detailed funding history for Korean vaccine
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Korean vaccine
Investment portfolio details for Korean vaccine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Korean vaccine
Detailed financials for Korean vaccine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Korean Vaccine Comparisons
Peer comparison for Korean vaccine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Korean vaccine
Korean vaccine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hospira, 410 Medical, Ivenix, Belmont Medical Technologies and IRadimed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Rapid infusion systems are provided for critically ill patients.
|
|
| Locked | Locked | Locked |
Infusion management systems are developed with wireless web-based architecture.
|
|
| Locked | Locked | Locked |
Fluid management and critical care medical devices are developed.
|
|
| Locked | Locked | Locked |
Developer of IV Infusion system and patient monitoring systems for the MRI setting
|
|
| Locked | Locked | Locked |
Medical devices for infusion therapy, monitoring, and radiology are manufactured.
|
Detailed competitors of Korean vaccine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Korean Vaccine
Complete news archive for Korean vaccine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Korean vaccine
Korean vaccine was founded in 1956.
Korean vaccine is headquartered in Ansan-si, South Korea. It is registered at Ansan-si, Gyeonggi-do, South Korea.
Korea Vaccine is a South Korean company that produces influenza vaccines and other bio pharmaceuticals, offering contract manufacturing, storage, and analytical services. It operates facilities in Ansan and Seoul, serving global clients through WHO-standard GMP compliance and overseas expansions like in Indonesia. The company focuses on RD for medical products and ensures ethical, environmentally safe operations.
Korean vaccine's top competitors include 410 Medical, IRadimed and Belmont Medical Technologies.
Korean vaccine offers Coboxflu4gaPF Injection, Coboxinplu4gaPF Injection, Syringe, Needle, and 2 more products and services.